Compare · HUM vs MDXH
HUM vs MDXH
Side-by-side comparison of Humana Inc. (HUM) and MDxHealth SA (MDXH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and MDXH operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $46.80B, about 621.8x MDXH ($75.3M).
- Over the past year, HUM is up 30.1% and MDXH is down 78.3% - HUM leads by 108.4 points.
- MDXH has been more active in the news (9 items in the past 4 weeks vs 6 for HUM).
- HUM has more recent analyst coverage (25 ratings vs 5 for MDXH).
- Company
- Humana Inc.
- MDxHealth SA
- Price
- $388.85+0.65%
- $0.79+5.09%
- Market cap
- $46.80B
- $75.3M
- 1M return
- +2.03%
- +92.16%
- 1Y return
- +30.12%
- -78.27%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 6
- 9
- Recent ratings
- 25
- 5
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
MDxHealth SA
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.
Latest HUM
- Humana Names Dr. Shantanu Nundy as Chief Medical Officer
- James P. Holland to Join Humana as Medicaid President
- Humana upgraded by Morgan Stanley with a new price target
- Humana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast Wisconsin
- Director Smith Paul John was granted 544 units of Humana Common (SEC Form 4)
- Director Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)
- Humana upgraded by Evercore ISI with a new price target
- Humana upgraded by Leerink Partners with a new price target
- Humana downgraded by Raymond James
- New insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)
Latest MDXH
- Amendment: SEC Form SCHEDULE 13G/A filed by MDxHealth SA
- Director Mvm Partners, Llc bought $1,000,000 worth of Ordinary Shares (2,202,643 units at $0.45) (SEC Form 4)
- SEC Form SCHEDULE 13D filed by MDxHealth SA
- These Biotech Breakouts and Squeeze Setups Could Be Just Getting Started
- SEC Form 6-K filed by MDxHealth SA
- SEC Form 424B5 filed by MDxHealth SA
- SEC Form 6-K filed by MDxHealth SA
- Mdxhealth Reports Second Quarter 2026 Financial Results
- Amendment: SEC Form SCHEDULE 13G/A filed by MDxHealth SA
- Mdxhealth to Release Second Quarter 2026 Financial Results on August 13